Industry Research Reports

Home > Reports > Medical Devices & Consumables > Rheumatoid Arthritis Testing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Rheumatoid Arthritis Testing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Devices & Consumables

Published: 2024-09-28

Pages: 104 Pages

Report ld: 3332079

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Rheumatoid arthritis is a long term severe disorder that directly affects the immune system of the human body. It is a serious disorder that comes with side effects such as swelling and inflammation around the affected area. Moreover, excessive pain is caused within body joints and organs of the body. The disease can affect several joints in the body, which in turn has led to a severe emphasis on the research and development of treatment options associated with the disease.

The global market for Rheumatoid Arthritis Testing was estimated to be worth US$ 2542 million in 2023 and is forecast to a readjusted size of US$ 4101 million by 2030 with a CAGR of 7.0% during the forecast period 2024-2030.

Rheumatoid Arthritis Testing Market Size

M= millions and B=billions

The rheumatoid arthritis (RA) testing market is experiencing growth, mainly due to the increase in the number of RA patients worldwide, the need for early diagnosis, and the continuous advancement of diagnostic technology. The main drivers of the market include technological advancement, the increase in the elderly population, the need for effective treatment options, and favorable health reimbursement policies. However, market growth also faces some challenges, such as test-related complications, the number of undiagnosed patients, and distrust of certain testing measures.

The top five players of rheumatoid arthritis testing in the world include Abbott Laboratories, F. Hoffmann-La Roche, Beckman Coulter, Siemens Healthineers, and Werfen, with a total market share of more than 57%, of which the largest manufacturer is F. Hoffmann -La Roche, with over 16% market share. China is the global most important consumer market for rheumatoid arthritis testing, with a market share of about 46%. In terms of type, the market share of serological tests is over 50%. In the application field, the market share of hospitals and clinics is about 60%.

In addition, the RA treatment market is also showing a trend of diversified development, including the development of biological drugs and targeted therapies, which provide better efficacy and safety by precisely targeting specific immune system components and inflammatory pathways. However, safety issues related to RA treatment may hinder patient acceptance and limit market growth.

Overall, both the RA detection and treatment markets face huge growth potential, but also need to overcome some challenges, such as improving the reliability of detection, reducing costs, raising public awareness of RA, and ensuring the safety and effectiveness of treatment.

The Rheumatoid Arthritis Testing market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rheumatoid Arthritis Testing.

Market Segmentation

Report Metric
Details
Report Title
Rheumatoid Arthritis Testing- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 4101 million
CAGR(2024-2030)
7%
Market Size Available for Years
2019-2030
Global Rheumatoid Arthritis Testing Companies Covered
Abbott Laboratories, F. Hoffmann-La Roche, Beckman Coulter, Siemens Healthineers, Augurex Life Sciences, Svar Life Science AB, Aviva Systems Biology, Bio-Rad Laboratories, Thermo Fisher Scientific, Microdrop, Werfen, Axis-Shield, Randox Laboratories, Guangzhou Leide Biosciences, Beijing Diagreat Biotechnologies
Global Rheumatoid Arthritis Testing Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Rheumatoid Arthritis Testing Market, Segment by Type
Serological Tests

Rheumatoid Arthritis Severity Tests and Medication Monitoring Tests

Imaging Tests

Others
Global Rheumatoid Arthritis Testing Market, Segment by Application
Hospitals and Clinics

Diagnostic Centers

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Rheumatoid Arthritis Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Rheumatoid Arthritis Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Rheumatoid Arthritis Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Rheumatoid Arthritis Testing Product Introduction
    1.2 Global Rheumatoid Arthritis Testing Market Size Forecast (2019-2030)
    1.3 Rheumatoid Arthritis Testing Market Trends & Drivers
        1.3.1 Rheumatoid Arthritis Testing Industry Trends
        1.3.2 Rheumatoid Arthritis Testing Market Drivers & Opportunity
        1.3.3 Rheumatoid Arthritis Testing Market Challenges
        1.3.4 Rheumatoid Arthritis Testing Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Rheumatoid Arthritis Testing Players Revenue Ranking (2023)
    2.2 Global Rheumatoid Arthritis Testing Revenue by Company (2019-2024)
    2.3 Key Companies Rheumatoid Arthritis Testing Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Rheumatoid Arthritis Testing Product Offered
    2.5 Key Companies Time to Begin Mass Production of Rheumatoid Arthritis Testing
    2.6 Rheumatoid Arthritis Testing Market Competitive Analysis
        2.6.1 Rheumatoid Arthritis Testing Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Rheumatoid Arthritis Testing Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatoid Arthritis Testing as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Serological Tests
        3.1.2 Rheumatoid Arthritis Severity Tests and Medication Monitoring Tests
        3.1.3 Imaging Tests
        3.1.4 Others
    3.2 Global Rheumatoid Arthritis Testing Sales Value by Type
        3.2.1 Global Rheumatoid Arthritis Testing Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Rheumatoid Arthritis Testing Sales Value, by Type (2019-2030)
        3.2.3 Global Rheumatoid Arthritis Testing Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospitals and Clinics
        4.1.2 Diagnostic Centers
        4.1.3 Others
    4.2 Global Rheumatoid Arthritis Testing Sales Value by Application
        4.2.1 Global Rheumatoid Arthritis Testing Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Rheumatoid Arthritis Testing Sales Value, by Application (2019-2030)
        4.2.3 Global Rheumatoid Arthritis Testing Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Rheumatoid Arthritis Testing Sales Value by Region
        5.1.1 Global Rheumatoid Arthritis Testing Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Rheumatoid Arthritis Testing Sales Value by Region (2019-2024)
        5.1.3 Global Rheumatoid Arthritis Testing Sales Value by Region (2025-2030)
        5.1.4 Global Rheumatoid Arthritis Testing Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Rheumatoid Arthritis Testing Sales Value, 2019-2030
        5.2.2 North America Rheumatoid Arthritis Testing Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Rheumatoid Arthritis Testing Sales Value, 2019-2030
        5.3.2 Europe Rheumatoid Arthritis Testing Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Rheumatoid Arthritis Testing Sales Value, 2019-2030
        5.4.2 Asia Pacific Rheumatoid Arthritis Testing Sales Value by Region (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Rheumatoid Arthritis Testing Sales Value, 2019-2030
        5.5.2 South America Rheumatoid Arthritis Testing Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Rheumatoid Arthritis Testing Sales Value, 2019-2030
        5.6.2 Middle East & Africa Rheumatoid Arthritis Testing Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Rheumatoid Arthritis Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Rheumatoid Arthritis Testing Sales Value, 2019-2030
    6.3 United States
        6.3.1 United States Rheumatoid Arthritis Testing Sales Value, 2019-2030
        6.3.2 United States Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Rheumatoid Arthritis Testing Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Rheumatoid Arthritis Testing Sales Value, 2019-2030
        6.4.2 Europe Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Rheumatoid Arthritis Testing Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Rheumatoid Arthritis Testing Sales Value, 2019-2030
        6.5.2 China Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Rheumatoid Arthritis Testing Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Rheumatoid Arthritis Testing Sales Value, 2019-2030
        6.6.2 Japan Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Rheumatoid Arthritis Testing Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Rheumatoid Arthritis Testing Sales Value, 2019-2030
        6.7.2 South Korea Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Rheumatoid Arthritis Testing Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Rheumatoid Arthritis Testing Sales Value, 2019-2030
        6.8.2 Southeast Asia Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Rheumatoid Arthritis Testing Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Rheumatoid Arthritis Testing Sales Value, 2019-2030
        6.9.2 India Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Rheumatoid Arthritis Testing Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Abbott Laboratories
        7.1.1 Abbott Laboratories Profile
        7.1.2 Abbott Laboratories Main Business
        7.1.3 Abbott Laboratories Rheumatoid Arthritis Testing Products, Services and Solutions
        7.1.4 Abbott Laboratories Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
        7.1.5 Abbott Laboratories Recent Developments
    7.2 F. Hoffmann-La Roche
        7.2.1 F. Hoffmann-La Roche Profile
        7.2.2 F. Hoffmann-La Roche Main Business
        7.2.3 F. Hoffmann-La Roche Rheumatoid Arthritis Testing Products, Services and Solutions
        7.2.4 F. Hoffmann-La Roche Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
        7.2.5 F. Hoffmann-La Roche Recent Developments
    7.3 Beckman Coulter
        7.3.1 Beckman Coulter Profile
        7.3.2 Beckman Coulter Main Business
        7.3.3 Beckman Coulter Rheumatoid Arthritis Testing Products, Services and Solutions
        7.3.4 Beckman Coulter Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
        7.3.5 Beckman Coulter Recent Developments
    7.4 Siemens Healthineers
        7.4.1 Siemens Healthineers Profile
        7.4.2 Siemens Healthineers Main Business
        7.4.3 Siemens Healthineers Rheumatoid Arthritis Testing Products, Services and Solutions
        7.4.4 Siemens Healthineers Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
        7.4.5 Siemens Healthineers Recent Developments
    7.5 Augurex Life Sciences
        7.5.1 Augurex Life Sciences Profile
        7.5.2 Augurex Life Sciences Main Business
        7.5.3 Augurex Life Sciences Rheumatoid Arthritis Testing Products, Services and Solutions
        7.5.4 Augurex Life Sciences Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
        7.5.5 Augurex Life Sciences Recent Developments
    7.6 Svar Life Science AB
        7.6.1 Svar Life Science AB Profile
        7.6.2 Svar Life Science AB Main Business
        7.6.3 Svar Life Science AB Rheumatoid Arthritis Testing Products, Services and Solutions
        7.6.4 Svar Life Science AB Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
        7.6.5 Svar Life Science AB Recent Developments
    7.7 Aviva Systems Biology
        7.7.1 Aviva Systems Biology Profile
        7.7.2 Aviva Systems Biology Main Business
        7.7.3 Aviva Systems Biology Rheumatoid Arthritis Testing Products, Services and Solutions
        7.7.4 Aviva Systems Biology Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
        7.7.5 Aviva Systems Biology Recent Developments
    7.8 Bio-Rad Laboratories
        7.8.1 Bio-Rad Laboratories Profile
        7.8.2 Bio-Rad Laboratories Main Business
        7.8.3 Bio-Rad Laboratories Rheumatoid Arthritis Testing Products, Services and Solutions
        7.8.4 Bio-Rad Laboratories Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
        7.8.5 Bio-Rad Laboratories Recent Developments
    7.9 Thermo Fisher Scientific
        7.9.1 Thermo Fisher Scientific Profile
        7.9.2 Thermo Fisher Scientific Main Business
        7.9.3 Thermo Fisher Scientific Rheumatoid Arthritis Testing Products, Services and Solutions
        7.9.4 Thermo Fisher Scientific Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
        7.9.5 Thermo Fisher Scientific Recent Developments
    7.10 Microdrop
        7.10.1 Microdrop Profile
        7.10.2 Microdrop Main Business
        7.10.3 Microdrop Rheumatoid Arthritis Testing Products, Services and Solutions
        7.10.4 Microdrop Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
        7.10.5 Microdrop Recent Developments
    7.11 Werfen
        7.11.1 Werfen Profile
        7.11.2 Werfen Main Business
        7.11.3 Werfen Rheumatoid Arthritis Testing Products, Services and Solutions
        7.11.4 Werfen Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
        7.11.5 Werfen Recent Developments
    7.12 Axis-Shield
        7.12.1 Axis-Shield Profile
        7.12.2 Axis-Shield Main Business
        7.12.3 Axis-Shield Rheumatoid Arthritis Testing Products, Services and Solutions
        7.12.4 Axis-Shield Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
        7.12.5 Axis-Shield Recent Developments
    7.13 Randox Laboratories
        7.13.1 Randox Laboratories Profile
        7.13.2 Randox Laboratories Main Business
        7.13.3 Randox Laboratories Rheumatoid Arthritis Testing Products, Services and Solutions
        7.13.4 Randox Laboratories Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
        7.13.5 Randox Laboratories Recent Developments
    7.14 Guangzhou Leide Biosciences
        7.14.1 Guangzhou Leide Biosciences Profile
        7.14.2 Guangzhou Leide Biosciences Main Business
        7.14.3 Guangzhou Leide Biosciences Rheumatoid Arthritis Testing Products, Services and Solutions
        7.14.4 Guangzhou Leide Biosciences Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
        7.14.5 Guangzhou Leide Biosciences Recent Developments
    7.15 Beijing Diagreat Biotechnologies
        7.15.1 Beijing Diagreat Biotechnologies Profile
        7.15.2 Beijing Diagreat Biotechnologies Main Business
        7.15.3 Beijing Diagreat Biotechnologies Rheumatoid Arthritis Testing Products, Services and Solutions
        7.15.4 Beijing Diagreat Biotechnologies Rheumatoid Arthritis Testing Revenue (US$ Million) & (2019-2024)
        7.15.5 Beijing Diagreat Biotechnologies Recent Developments

 8 Industry Chain Analysis
    8.1 Rheumatoid Arthritis Testing Industrial Chain
    8.2 Rheumatoid Arthritis Testing Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Rheumatoid Arthritis Testing Sales Model
        8.5.2 Sales Channel
        8.5.3 Rheumatoid Arthritis Testing Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Rheumatoid Arthritis Testing Market Trends
 Table 2. Rheumatoid Arthritis Testing Market Drivers & Opportunity
 Table 3. Rheumatoid Arthritis Testing Market Challenges
 Table 4. Rheumatoid Arthritis Testing Market Restraints
 Table 5. Global Rheumatoid Arthritis Testing Revenue by Company (2019-2024) & (US$ Million)
 Table 6. Global Rheumatoid Arthritis Testing Revenue Market Share by Company (2019-2024)
 Table 7. Key Companies Rheumatoid Arthritis Testing Manufacturing Base Distribution and Headquarters
 Table 8. Key Companies Rheumatoid Arthritis Testing Product Type
 Table 9. Key Companies Time to Begin Mass Production of Rheumatoid Arthritis Testing
 Table 10. Global Rheumatoid Arthritis Testing Companies Market Concentration Ratio (CR5 and HHI)
 Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatoid Arthritis Testing as of 2023)
 Table 12. Mergers & Acquisitions, Expansion Plans
 Table 13. Global Rheumatoid Arthritis Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
 Table 14. Global Rheumatoid Arthritis Testing Sales Value by Type (2019-2024) & (US$ Million)
 Table 15. Global Rheumatoid Arthritis Testing Sales Value by Type (2025-2030) & (US$ Million)
 Table 16. Global Rheumatoid Arthritis Testing Sales Market Share in Value by Type (2019-2024)
 Table 17. Global Rheumatoid Arthritis Testing Sales Market Share in Value by Type (2025-2030)
 Table 18. Global Rheumatoid Arthritis Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
 Table 19. Global Rheumatoid Arthritis Testing Sales Value by Application (2019-2024) & (US$ Million)
 Table 20. Global Rheumatoid Arthritis Testing Sales Value by Application (2025-2030) & (US$ Million)
 Table 21. Global Rheumatoid Arthritis Testing Sales Market Share in Value by Application (2019-2024)
 Table 22. Global Rheumatoid Arthritis Testing Sales Market Share in Value by Application (2025-2030)
 Table 23. Global Rheumatoid Arthritis Testing Sales Value by Region, (2019 VS 2023 VS 2030) & (US$ Million)
 Table 24. Global Rheumatoid Arthritis Testing Sales Value by Region (2019-2024) & (US$ Million)
 Table 25. Global Rheumatoid Arthritis Testing Sales Value by Region (2025-2030) & (US$ Million)
 Table 26. Global Rheumatoid Arthritis Testing Sales Value by Region (2019-2024) & (%)
 Table 27. Global Rheumatoid Arthritis Testing Sales Value by Region (2025-2030) & (%)
 Table 28. Key Countries/Regions Rheumatoid Arthritis Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
 Table 29. Key Countries/Regions Rheumatoid Arthritis Testing Sales Value, (2019-2024) & (US$ Million)
 Table 30. Key Countries/Regions Rheumatoid Arthritis Testing Sales Value, (2025-2030) & (US$ Million)
 Table 31. Abbott Laboratories Basic Information List
 Table 32. Abbott Laboratories Description and Business Overview
 Table 33. Abbott Laboratories Rheumatoid Arthritis Testing Products, Services and Solutions
 Table 34. Revenue (US$ Million) in Rheumatoid Arthritis Testing Business of Abbott Laboratories (2019-2024)
 Table 35. Abbott Laboratories Recent Developments
 Table 36. F. Hoffmann-La Roche Basic Information List
 Table 37. F. Hoffmann-La Roche Description and Business Overview
 Table 38. F. Hoffmann-La Roche Rheumatoid Arthritis Testing Products, Services and Solutions
 Table 39. Revenue (US$ Million) in Rheumatoid Arthritis Testing Business of F. Hoffmann-La Roche (2019-2024)
 Table 40. F. Hoffmann-La Roche Recent Developments
 Table 41. Beckman Coulter Basic Information List
 Table 42. Beckman Coulter Description and Business Overview
 Table 43. Beckman Coulter Rheumatoid Arthritis Testing Products, Services and Solutions
 Table 44. Revenue (US$ Million) in Rheumatoid Arthritis Testing Business of Beckman Coulter (2019-2024)
 Table 45. Beckman Coulter Recent Developments
 Table 46. Siemens Healthineers Basic Information List
 Table 47. Siemens Healthineers Description and Business Overview
 Table 48. Siemens Healthineers Rheumatoid Arthritis Testing Products, Services and Solutions
 Table 49. Revenue (US$ Million) in Rheumatoid Arthritis Testing Business of Siemens Healthineers (2019-2024)
 Table 50. Siemens Healthineers Recent Developments
 Table 51. Augurex Life Sciences Basic Information List
 Table 52. Augurex Life Sciences Description and Business Overview
 Table 53. Augurex Life Sciences Rheumatoid Arthritis Testing Products, Services and Solutions
 Table 54. Revenue (US$ Million) in Rheumatoid Arthritis Testing Business of Augurex Life Sciences (2019-2024)
 Table 55. Augurex Life Sciences Recent Developments
 Table 56. Svar Life Science AB Basic Information List
 Table 57. Svar Life Science AB Description and Business Overview
 Table 58. Svar Life Science AB Rheumatoid Arthritis Testing Products, Services and Solutions
 Table 59. Revenue (US$ Million) in Rheumatoid Arthritis Testing Business of Svar Life Science AB (2019-2024)
 Table 60. Svar Life Science AB Recent Developments
 Table 61. Aviva Systems Biology Basic Information List
 Table 62. Aviva Systems Biology Description and Business Overview
 Table 63. Aviva Systems Biology Rheumatoid Arthritis Testing Products, Services and Solutions
 Table 64. Revenue (US$ Million) in Rheumatoid Arthritis Testing Business of Aviva Systems Biology (2019-2024)
 Table 65. Aviva Systems Biology Recent Developments
 Table 66. Bio-Rad Laboratories Basic Information List
 Table 67. Bio-Rad Laboratories Description and Business Overview
 Table 68. Bio-Rad Laboratories Rheumatoid Arthritis Testing Products, Services and Solutions
 Table 69. Revenue (US$ Million) in Rheumatoid Arthritis Testing Business of Bio-Rad Laboratories (2019-2024)
 Table 70. Bio-Rad Laboratories Recent Developments
 Table 71. Thermo Fisher Scientific Basic Information List
 Table 72. Thermo Fisher Scientific Description and Business Overview
 Table 73. Thermo Fisher Scientific Rheumatoid Arthritis Testing Products, Services and Solutions
 Table 74. Revenue (US$ Million) in Rheumatoid Arthritis Testing Business of Thermo Fisher Scientific (2019-2024)
 Table 75. Thermo Fisher Scientific Recent Developments
 Table 76. Microdrop Basic Information List
 Table 77. Microdrop Description and Business Overview
 Table 78. Microdrop Rheumatoid Arthritis Testing Products, Services and Solutions
 Table 79. Revenue (US$ Million) in Rheumatoid Arthritis Testing Business of Microdrop (2019-2024)
 Table 80. Microdrop Recent Developments
 Table 81. Werfen Basic Information List
 Table 82. Werfen Description and Business Overview
 Table 83. Werfen Rheumatoid Arthritis Testing Products, Services and Solutions
 Table 84. Revenue (US$ Million) in Rheumatoid Arthritis Testing Business of Werfen (2019-2024)
 Table 85. Werfen Recent Developments
 Table 86. Axis-Shield Basic Information List
 Table 87. Axis-Shield Description and Business Overview
 Table 88. Axis-Shield Rheumatoid Arthritis Testing Products, Services and Solutions
 Table 89. Revenue (US$ Million) in Rheumatoid Arthritis Testing Business of Axis-Shield (2019-2024)
 Table 90. Axis-Shield Recent Developments
 Table 91. Randox Laboratories Basic Information List
 Table 92. Randox Laboratories Description and Business Overview
 Table 93. Randox Laboratories Rheumatoid Arthritis Testing Products, Services and Solutions
 Table 94. Revenue (US$ Million) in Rheumatoid Arthritis Testing Business of Randox Laboratories (2019-2024)
 Table 95. Randox Laboratories Recent Developments
 Table 96. Guangzhou Leide Biosciences Basic Information List
 Table 97. Guangzhou Leide Biosciences Description and Business Overview
 Table 98. Guangzhou Leide Biosciences Rheumatoid Arthritis Testing Products, Services and Solutions
 Table 99. Revenue (US$ Million) in Rheumatoid Arthritis Testing Business of Guangzhou Leide Biosciences (2019-2024)
 Table 100. Guangzhou Leide Biosciences Recent Developments
 Table 101. Beijing Diagreat Biotechnologies Basic Information List
 Table 102. Beijing Diagreat Biotechnologies Description and Business Overview
 Table 103. Beijing Diagreat Biotechnologies Rheumatoid Arthritis Testing Products, Services and Solutions
 Table 104. Revenue (US$ Million) in Rheumatoid Arthritis Testing Business of Beijing Diagreat Biotechnologies (2019-2024)
 Table 105. Beijing Diagreat Biotechnologies Recent Developments
 Table 106. Key Raw Materials Lists
 Table 107. Raw Materials Key Suppliers Lists
 Table 108. Rheumatoid Arthritis Testing Downstream Customers
 Table 109. Rheumatoid Arthritis Testing Distributors List
 Table 110. Research Programs/Design for This Report
 Table 111. Key Data Information from Secondary Sources
 Table 112. Key Data Information from Primary Sources
 Table 113. Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Rheumatoid Arthritis Testing Product Picture
 Figure 2. Global Rheumatoid Arthritis Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
 Figure 3. Global Rheumatoid Arthritis Testing Sales Value (2019-2030) & (US$ Million)
 Figure 4. Rheumatoid Arthritis Testing Report Years Considered
 Figure 5. Global Rheumatoid Arthritis Testing Players Revenue Ranking (2023) & (US$ Million)
 Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Rheumatoid Arthritis Testing Revenue in 2023
 Figure 7. Rheumatoid Arthritis Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 8. Serological Tests Picture
 Figure 9. Rheumatoid Arthritis Severity Tests and Medication Monitoring Tests Picture
 Figure 10. Imaging Tests Picture
 Figure 11. Others Picture
 Figure 12. Global Rheumatoid Arthritis Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
 Figure 13. Global Rheumatoid Arthritis Testing Sales Value Market Share by Type, 2023 & 2030
 Figure 14. Product Picture of Hospitals and Clinics
 Figure 15. Product Picture of Diagnostic Centers
 Figure 16. Product Picture of Others
 Figure 17. Global Rheumatoid Arthritis Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
 Figure 18. Global Rheumatoid Arthritis Testing Sales Value Market Share by Application, 2023 & 2030
 Figure 19. North America Rheumatoid Arthritis Testing Sales Value (2019-2030) & (US$ Million)
 Figure 20. North America Rheumatoid Arthritis Testing Sales Value by Country (%), 2023 VS 2030
 Figure 21. Europe Rheumatoid Arthritis Testing Sales Value, (2019-2030) & (US$ Million)
 Figure 22. Europe Rheumatoid Arthritis Testing Sales Value by Country (%), 2023 VS 2030
 Figure 23. Asia Pacific Rheumatoid Arthritis Testing Sales Value, (2019-2030) & (US$ Million)
 Figure 24. Asia Pacific Rheumatoid Arthritis Testing Sales Value by Region (%), 2023 VS 2030
 Figure 25. South America Rheumatoid Arthritis Testing Sales Value, (2019-2030) & (US$ Million)
 Figure 26. South America Rheumatoid Arthritis Testing Sales Value by Country (%), 2023 VS 2030
 Figure 27. Middle East & Africa Rheumatoid Arthritis Testing Sales Value, (2019-2030) & (US$ Million)
 Figure 28. Middle East & Africa Rheumatoid Arthritis Testing Sales Value by Country (%), 2023 VS 2030
 Figure 29. Key Countries/Regions Rheumatoid Arthritis Testing Sales Value (%), (2019-2030)
 Figure 30. United States Rheumatoid Arthritis Testing Sales Value, (2019-2030) & (US$ Million)
 Figure 31. United States Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
 Figure 32. United States Rheumatoid Arthritis Testing Sales Value by Application (%), 2023 VS 2030
 Figure 33. Europe Rheumatoid Arthritis Testing Sales Value, (2019-2030) & (US$ Million)
 Figure 34. Europe Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
 Figure 35. Europe Rheumatoid Arthritis Testing Sales Value by Application (%), 2023 VS 2030
 Figure 36. China Rheumatoid Arthritis Testing Sales Value, (2019-2030) & (US$ Million)
 Figure 37. China Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
 Figure 38. China Rheumatoid Arthritis Testing Sales Value by Application (%), 2023 VS 2030
 Figure 39. Japan Rheumatoid Arthritis Testing Sales Value, (2019-2030) & (US$ Million)
 Figure 40. Japan Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
 Figure 41. Japan Rheumatoid Arthritis Testing Sales Value by Application (%), 2023 VS 2030
 Figure 42. South Korea Rheumatoid Arthritis Testing Sales Value, (2019-2030) & (US$ Million)
 Figure 43. South Korea Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
 Figure 44. South Korea Rheumatoid Arthritis Testing Sales Value by Application (%), 2023 VS 2030
 Figure 45. Southeast Asia Rheumatoid Arthritis Testing Sales Value, (2019-2030) & (US$ Million)
 Figure 46. Southeast Asia Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
 Figure 47. Southeast Asia Rheumatoid Arthritis Testing Sales Value by Application (%), 2023 VS 2030
 Figure 48. India Rheumatoid Arthritis Testing Sales Value, (2019-2030) & (US$ Million)
 Figure 49. India Rheumatoid Arthritis Testing Sales Value by Type (%), 2023 VS 2030
 Figure 50. India Rheumatoid Arthritis Testing Sales Value by Application (%), 2023 VS 2030
 Figure 51. Rheumatoid Arthritis Testing Industrial Chain
 Figure 52. Rheumatoid Arthritis Testing Manufacturing Cost Structure
 Figure 53. Channels of Distribution (Direct Sales, and Distribution)
 Figure 54. Bottom-up and Top-down Approaches for This Report
 Figure 55. Data Triangulation
 Figure 56. Key Executives Interviewed

Description

Rheumatoid arthritis is a long term severe disorder that directly affects the immune system of the human body. It is a serious disorder that comes with side effects such as swelling and inflammation around the affected area. Moreover, excessive pain is caused within body joints and organs of the body. The disease can affect several joints in the body, which in turn has led to a severe emphasis on the research and development of treatment options associated with the disease.

The global market for Rheumatoid Arthritis Testing was estimated to be worth US$ 2542 million in 2023 and is forecast to a readjusted size of US$ 4101 million by 2030 with a CAGR of 7.0% during the forecast period 2024-2030.

Market Segmentation